Skip to content
Find an ETF
← All ETFs

Available in 10 markets

Invesco STOXX Europe 600 Optimised Chemicals UCITS ETF Acc

Invesco · IE00B5MTY077

Invesco STOXX Europe 600 Optimised Chemicals UCITS ETF Acc is an exchange-traded fund (ETF) from Invesco, traded under the ticker 0MTG (ISIN IE00B5MTY077). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their…

· Tracks the STOXX® Europe 600 Optimised Chemicals Total Return (Net) Index index ?
Equity ?Accumulating ?Synthetic ?Ireland ?
Low yearly feeReinvests dividendsUses a swapEuropeConcentrated in a few names
Fund size (AUM) ?
€259M
Risk level (SRI) ?
4 / 7 · Medium
1-year return ?
-0.0%
Total return · to 2026-07-20
Yearly fee (TER) ?
0.20%
All-in cost ≈ 0.20%

About this fund

What you own

The STOXX® Europe 600 Optimised Chemicals Total Return (Net) Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 114 companies across Europe in a single purchase.

Dividends

The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.

Read more

Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.

How it works

The fund uses a swap contract with a bank to mirror the index, instead of holding the shares directly.

Read more

Rather than hold the shares, the fund signs a swap with a bank that agrees to pay it the index return. This can track some markets very tightly and cheaply, but it adds counterparty risk — the small chance the swap partner cannot pay — which regulated funds limit and back with collateral. It reaches the same index a different way, with a different set of trade-offs to physical funds.

Cost

0.20%Yearly fee (TER)
0.20%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Index tracked ?
STOXX® Europe 600 Optimised Chemicals Total Return (Net) Index
Replication ?
Synthetic
Uses a swap contract
Regulation ?
UCITS
Yes
Launched
Jul 2009
17-year track record
Recommended holding period
5 years

Performance

77.984.490.897.3104202120242026

Growth of €100 invested — the line starts at €100.

Invesco STOXX Europe 600 Optimised Chemicals UCITS ETF Acc

End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.

YTD+14.3%
1 year-0.0%
3 years+2.5%

Return, year by year

-14.8
+13.9
-1.9
-9.2
'22'23'24'25
1 of 4 up yearsBest: 2023 +13.9%Worst: 2022 -14.8%Calendar-year total returns, in EUR

How bumpy has it been?

25.1%
Volatility (1y) ?
How much the price swings year to year — lower is calmer.
-20.1%
Worst drop (3y) ?
The biggest fall from a peak over the last three years.

The bigger picture

-2.0%
Since inception
Total growth since launch — about -0.4% a year.
+15.5%
Best 12 months
The strongest one-year stretch on record.
-17.8%
Worst 12 months
The weakest one-year stretch on record.
-21.6%
Worst fall on record ?
It clawed back in about 17 months.

What's inside

By sector ?

Health Care20.3%
Industrials15.4%
Financials14.9%
Consumer Discretionary12.8%
Technology11.3%
Consumer Staples9.9%
Materials6.6%
Cash/Other4.2%

The 10 biggest holdings make up 44.6% of the fund.

Top 10 holdings

#CompanyWeight
1NESTLE SA-REG7.8%
2NOVARTIS AG-REG7.2%
3AMAZON.COM INC5.4%
4ZURICH INSURANCE GROUP AG4.8%
5ABB LTD-REG4.1%
6CIE FINANCIERE RICHEMO-A REG3.9%
7LONZA GROUP AG-REG3.6%
8ROCHE HOLDING AG3.3%
9NVIDIA CORP2.5%
10YARA INTERNATIONAL ASA2.2%

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
LSE0MTGEUR★ Primary
EUR listings
B2X4PSEUR
B3SC00DEUR
B4X4PSEUR
E1X4PSEUR
EOX4PSEUR
EPX4PSEUR
EUX4PSEUR
EZX4PSEUR
FrankfurtX4PSEUR
GDX4PSEUR
GFX4PSEUR
GHX4PSEUR
GMX4PSEUR
GSX4PSEUR
GTX4PSEUR
GZSC00EUR
L1SC00DEUR
L3SC00DEUR
LAX4PSEUR
London Stock Exchange0MTGEUR
LUX4PSEUR
POSC00DEUR
QTSC00EUR
S1SC00DEUR
S4SC00DEUR
T2X4PSEUR
THSC00EUR
X9X4PSEUR
XEX4PSEUR
XLX4PSEUR
XSX4PSEUR
XVX4PSEUR
XWX4PSEUR
XXX4PSEUR
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

How it ranks vs peers

🪙 Cheaper than 49% of similar ETFs💰 All-in cost cheaper than 55%📈 Higher 1-yr return than 6%📈 Higher 3-yr return than 13%📊 Behind its category by 17.7% (1-yr) (category average +17.7%)📊 Behind its category by 10.2% (3-yr) (category average +12.7%)

Versus the Equity (stocks) · Europe · EUR ETFs we track.

Advanced risk

0.11
Sortino (3y) ?
0.12
Calmar (3y) ?
16.2%
Downside deviation ?
63%
Up months (hit rate) ?
€629.10
52-week high ?
€519.60
52-week low ?

Tilt vs a world tracker

United States-48.2
Switzerland+35.8
Technology-17.9
Health Care+10.9
Denmark+7.7
Sweden+7.0

Percentage points over / under a broad world-equity tracker (not a licensed benchmark).

Estimated fund flows

+€5.3M
Estimated net flow, last month

Estimated from fund-size changes.

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 Europe stocks
Compare side by side
6 similar funds
Invesco STOXX Europe 600 Optimised Chemicals UCITS ETF AccInvescoYou're viewingInvesco S&P 500 UCITS ETF EUR Hdg AccInvescoBroader matchAmundi Core S&P 500 Swap UCITS ETF EUR Hedged AccAmundiBroader matchAmundi Core S&P 500 Swap UCITS ETF EUR Hedged DistAmundiBroader matchAmundi Core Stoxx Europe 600 UCITS ETF AccAmundiBroader matchAmundi Core Stoxx Europe 600 UCITS ETF USD Hedged AccAmundiBroader matchAmundi Core Stoxx Europe 600 UCITS ETF EUR Hedged DistAmundiBroader match
Why it's similarThis is the fund on this page.
StocksAccumulatingSyntheticCheaper fee
Tracks a different index in the same category.
StocksAccumulatingSyntheticCheaper fee
Tracks a different index in the same category.
StocksSyntheticCheaper fee
Tracks a different index in the same category.
StocksAccumulatingCheaper fee
Tracks a different index in the same category.
StocksAccumulatingCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
Index trackedSTOXX® Europe 600 Optimised Chemicals Total Return (Net) IndexS&P 500 Daily Hedged Euro Net Total Return IndexS&P 500 Daily Hedged Euro Index Net TRS&P 500 Daily Hedged Euro Index Net TRSTOXX Europe 600 (Net Return) EURSTOXX Europe 600 (Net Return) EURSTOXX Europe 600 (Net Return) EUR
Yearly fee (TER)0.20%0.05%0.07%0.07%0.07%0.09%0.15%
All-in cost0.20%0.45%0.00%0.07%0.07%0.09%0.15%
Fund size€259M€50.6B€28.7B€28.5B€21.7B€21.6B€21.4B
DomicileIrelandIrelandLULULULULU
ReplicationSynthetic (swap)Synthetic (swap)Synthetic (swap)Synthetic (swap)Physical (full)Physical (full)Physical (full)
3-yr return p.a.+2.5%+20.0%+19.0%
5-yr return p.a.+10.5%+9.5%
# holdings1142941010613613613

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-07-20 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.